Three Failed Letrozole Cycles in a Woman with PCOS and Obesity
A 29-year-old nulliparous woman with a body mass index of 34 kg/m² has been trying to conceive for 15 months. She has polycystic ovary syndrome by the Rotterdam criteria and cycles every 45–90 days. Her partner's semen analysis is normal (concentration 48 million/mL, progressive motility 45%, normal morphology 6%). Hysterosalpingography shows bilateral patent tubes. TSH is 2.1 mIU/L, prolactin is normal, HbA1c is 5.7%, and she has no acne or hirsutism. She has completed three cycles of letrozole 5 mg on days 2–6 with ovulation confirmed by mid-luteal progesterone, but has not conceived. She is keen to try something stronger and asks about injections.
1. What are the options now, and what is the evidence for each?
Read the worked answer
First, check what 'three cycles' actually means. Three ovulatory cycles is a small sample; most couples conceive within six ovulatory cycles, and both NICE and ASRM would support continuing letrozole for up to six cycles before escalating. Confirm ovulation was genuinely documented (mid-luteal progesterone above about 16 nmol/L, or a follicle on scan) and that intercourse timing was adequate.
Realistic options, in order of invasiveness
- Letrozole 7.5 mg, with or without metformin 1500–2000 mg daily. Dose escalation is cheap; metformin improves ovulation rates and may improve live birth in obese women with PCOS, and reduces gestational diabetes risk.
- Weight loss of 5–10%. Not a soft option: it restores ovulation in a substantial proportion and improves response to every other treatment.
- Gonadotrophins by low-dose step-up. Effective, with cumulative live birth around 20–25% per cycle in clomiphene-resistant PCOS, but requires monitoring.
- Laparoscopic ovarian drilling. Live birth comparable to gonadotrophins in some trials and avoids multiple pregnancy, but it is surgical and reduces ovarian reserve.
- IVF. Best per-cycle success; a freeze-all strategy keeps OHSS risk low.
What I would recommend. Continue letrozole at 7.5 mg for three more cycles with metformin and a structured weight programme, then move to gonadotrophins or IVF. Escalating immediately is defensible, but not on the basis of three cycles.
2. She chooses gonadotrophins. What are the specific risks and how do you mitigate them?
Read the worked answer
Risks
- Multiple pregnancy - around 10–25% with gonadotrophins, far higher than with letrozole, and the main driver of preterm birth, pre-eclampsia and neonatal morbidity.
- Ovarian hyperstimulation syndrome - low with true low-dose step-up (under 2%) but higher if the dose is escalated quickly or hCG is given in a multifollicular response.
- Cycle cancellation and cost, plus the burden of injections and monitoring.
- Ectopic pregnancy and, rarely, adnexal torsion.
Mitigation
- Start at 37.5–75 IU FSH daily, step up by no more than 37.5 IU every 7 days, and do not increase when there is a response.
- Transvaginal ultrasound (and oestradiol where available) before hCG; cancel or convert to IVF if more than two or three follicles reach 16 mm.
- Never give hCG to trigger in a hyperstimulated response.
- Record a multiple-pregnancy discussion, and offer fetal reduction counselling if it occurs.
- Consider a freeze-all IVF cycle instead when she has a multifollicular response - often the safer route in PCOS.
Counselling line. 'Injections give you a better chance per cycle than tablets, but also a much higher chance of twins or triplets, which is why we scan you.'
3. She asks whether she should go straight to IVF and whether her weight matters.
Read the worked answer
Does weight matter? Yes, and it changes the arithmetic of every option. At a BMI of 34, spontaneous ovulation is less likely, response to letrozole and gonadotrophins is reduced, and the risks of miscarriage, gestational diabetes, pre-eclampsia, macrosomia and caesarean delivery are all raised. A 5–10% loss often restores ovulation on its own and improves live birth. Bariatric surgery is effective, but pregnancy should be deferred for 12–18 months afterwards and micronutrient deficiencies corrected.
Should she go straight to IVF? IVF has the highest live-birth rate per cycle, and with an antagonist protocol, agonist trigger, freeze-all and single embryo transfer, OHSS and multiple-pregnancy risks can be minimised. But it is expensive and invasive, and in a 29-year-old with patent tubes and normal semen it is not clearly superior to six ovulatory letrozole cycles.
A defensible plan. Set a time frame with her: three more cycles of upscaled letrozole plus metformin plus a structured weight programme, then six monitored gonadotrophin cycles aiming for a single follicle, then IVF. Review at each stage and give her the numbers so the choice is hers. Meanwhile, give a progestin withdrawal bleed and cyclical progesterone to protect the endometrium while she remains anovulatory.